Oncology RN, 4S: Chemotherapy & Palliative Care

Cedars-Sinai; Los Angeles (CA); Sur place; USD 110 000 - 140 000; Plein temps

Avantages offerts par ce poste

Employee Referral Program bonus

Résumé du poste

Cedars-Sinai Hospital in Los Angeles is seeking a Registered Nurse for 4South, our Oncology/Cellular Therapy/Hospice unit. You will deliver direct and indirect patient care, participate in interdisciplinary planning, and support education and safety for diverse patient populations.

The role requires a California RN license, BSN or higher is preferred, ACLS, and a strong oncology background. Experience with chemotherapy and related therapies is highly valued.

Qualifications

• Graduate of an accredited nursing program; BSN or higher preferred.
• Current California State RN License required upon hire.
• ACLS certification required upon hire.
• Oncology/chemotherapy certification encouraged within 1 year of hire.
• 3+ years of acute RN experience in a specialty unit.

Responsabilités

• Provide and document direct and indirect patient care in a timely manner.
• Educate patients on prevention, disease management, and care plans.
• Administer medications and therapies per plan of care.
• Perform skin tests, phlebotomy, and peripheral venous access as needed.
• Observe patient status and respond to changes per protocol.
• Develop individualized care plans; coordinate with diverse teams.
• Assess readiness for learning and ensure patient safety across ages.

Connaissances

Nursing

Patient care

Communication

Teamwork

Formation

BSN or higher

California RN License

Description du poste

Cedars-Sinai Hospital in Los Angeles is seeking a Registered Nurse for 4South, our Oncology/Cellular Therapy/Hospice unit. You will deliver direct and indirect patient care, participate in interdisciplinary planning, and support education and safety for diverse patient populations.

The role requires a California RN license, BSN or higher is preferred, ACLS, and a strong oncology background. Experience with chemotherapy and related therapies is highly valued.